NOVONIX Limited February 2025 Financial Report: Compliance & ASX Response

Key Information from the Financial Report (Form 6-K)

Registrant Information:

Name: NOVONIX LIMITED
Commission File Number: 001-41208
Principal Executive Office Address:
- Level 38, 71 Eagle Street
- Brisbane, QLD 4000, Australia

Filing Purpose:

This report is being filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
The report is for the month of February 2025.

Form Submission:

The registrant has indicated its intention to submit annual reports under Form 20-F.
No indication of submission under Form 40-F.

Exhibit Index:

Exhibit 99.1: ASX Announcement (Response to ASX Aware Letter) filed on February 19, 2025.

Signature:

The report is signed by:
- Name: Robert Long
- Title: Chief Executive Officer
- Date: February 24, 2025

Insights

Regulatory Compliance: The filing of Form 6-K indicates compliance with U.S. SEC regulations, allowing for timely communication of important company information.
Response to ASX: The inclusion of a response to an ASX Aware Letter suggests that the company is actively managing communications with its investors and stakeholders, which may reflect transparency and responsiveness to regulatory inquiries or market conditions.
Location Details: The registrant's address in Brisbane, Australia, may indicate its operational base and provide context for its geographical market focus.
Annual Reporting: The intention to file under Form 20-F suggests that NOVONIX is preparing for comprehensive annual disclosures, typical for foreign registrants listed on U.S. exchanges, emphasizing its global operational footprint.

This summary highlights the essential components of the filing relevant to investors and stakeholders, showcasing NOVONIX's compliance and proactive communication strategies.